Tracy Pena
Nurse Practitioner · Alice, TXNPI 1760747943
Payments from drug & device makers
Across 853 payments — averaging $16.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$3K
- Lilly USA, LLC$2K
- AbbVie$1K
- Pfizer$743
- Amgen$731
- Boehringer Ingelheim$634
- plus $5K from 35 others
What the payments were for
- Food & beverage$13,723100%
- Education$330%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,756 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 108 | $153,928 |
| JardianceEmpagliflozin | 84 | $96,272 |
| TrulicityDulaglutide | 60 | $84,493 |
| MounjaroTirzepatide | 34 | $65,437 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 42 | $46,503 |
| FarxigaDapagliflozin Propanediol | 32 | $45,534 |
| XareltoRivaroxaban | 30 | $33,909 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 39 | $33,367 |
| EliquisApixaban | 25 | $28,592 |
| Repatha SureclickEvolocumab | 22 | $22,019 |
| JanuviaSitagliptin Phosphate | 27 | $21,577 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $19,992 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $18,216 |
| Tresiba Flextouch U-200Insulin Degludec | 20 | $17,617 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $17,508 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $3,222 | $153,928108 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $1,898 | $149,93094 claims |
| Boehringer IngelheimJardiance | $634 | $96,27284 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $402 | $76,08697 claims |
| Johnson & JohnsonXarelto | $100 | $33,90930 claims |
| PfizerEliquis, Paxlovid | $743 | $29,96036 claims |
| MerckJanuvia | $218 | $21,57727 claims |
| GSKTrelegy Ellipta | $312 | $19,99220 claims |
| AbbVieLinzess | $1,459 | $15,61215 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $173 | $14,72211 claims |
| Astellas Pharma US IncMyrbetriq | $165 | $14,03915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in Alice
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Kelly BrassilHouston$194K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Monica WhiteLongview$118K
- Onna FeuchterSouthlake$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.